Auto-regulation of the estrogen receptor promoter

Journal of Steroid Biochemistry and Molecular Biology

Volumn 62, Issue 2-3, 1997, Pages 155-163

  Castles, C G ^a   Oesterreich, S ^a   Hansen, R ^a   Fuqua, S A W ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST TUMOR; CELL LINE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC ANALYSIS; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PLASMID; PROMOTER REGION;

AUTOCRINE COMMUNICATION; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; TRANSFECTION;

EID: 0030722152     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00023-X     Document Type: Article

References (42)

1. McGuire, W. L., Carbone, P. P. and Vollmer, E. P., Estrogen Receptors in Human Breast Cancer, Raven Press, New York.
2. Ricketts D., Turnbull L., Ryall G., Bakhshi R., Rawson N. S. B., Gazet J.-C., Nolan G. and Coombes R. C., Estrogen and progesterone receptors in the normal female breast. Cancer Research 51 (1991) 1817-1822.
3. Hill S. M., Fuqua S. A. W., Chamness G. C., Greene G. L. McGuire W. L., Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Research 49 (1989) 145-148.
4. Roodi N., Bailey L. R., Kao W. Y., Verrier C. S., Yee C. J., Dupont W. D. and Parl F. F., Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. Journal of the National Cancer Institute 87 (1995) 446-451.
5. Koh E. H., Wildrick D. M., Hortobagyi G. N. and Blick M., Analysis of the estrogen receptor gene structure in human breast cancer. Anticancer Research 9 (1989) 1841-1846.
6. Nembrot M., Quintana B. and Mordoh J., Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors. Biochemical and Biophysical Research Communications 166 (1990) 601-607.
7. Keaveney M., Klug J., Dawson M. T., Nestor P. V., Neilan J. G., Forde R. C. and Gannon F., Evidence of a previously unidentified upstream exon in the human oestrogen receptor gene. Journal of Molecular Endocrinology 6 (1991) 111-115.
8. Piva R., Gambari R., Zorzato F., Kumar L. and del Senno L., Analysis of upstream sequences of the human estrogen receptor gene. Biochemical and Biophysical Research Communications 183 (1992) 996-1002.
9. Green S., Walter P., Kumar V., Krust A., Bornert J.-M., Argos P. and Chambon P., Human oestrogen receptor cDNA; sequence, expression and homology to v-erbA. Nature 320 (1986) 134-139.
10. Greene G. L., Gilna P., Walterfield M., Baker A., Hort Y. and Shine J., Sequence and expression of human estrogen receptor cDNA. Science 231 (1986) 1150-1154.
11. deConinck E. C., McPherson L. A. and Weigel R. J., Transcriptional regulation of estrogen receptor in breast carcinomas. Molecular and Cellular Biology 15 (1995) 2191-2196.
12. Ottaviano Y. L., Issa J. P., Parl F. F., Smith H. S., Baylin S. B. and Davidson N. E., Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Research 54 (1994) 2552-2555.
13. Saceda M., Lippman M. E., Chambon P., Lindsey R. L., Ponglikitmongkol M., Puente M. and Martin M. B., Regulation of the estrogen receptor in MCF-7 cells by estradiol. Molecular Endocrinology 2 (1988) 1157-1162.
14. Read L. D., Greene G. and Katzenellenbogen B. S., Regulation of estrogen receptor messsenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Molecular Endocrinology 3 (1989) 295-304.
15. Fuqua, S. A. W., Estrogen and progesterone receptors and breast cancer. In Diseases of the Breast, eds J. R. Harris, M. Lippman, M. Morrow, and S. Hellman, Lippincott-Raven Publishers, 1996, pp. 261-271.
16. Danielian P. S., White R., Lees J. A. and Parker M. G., Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO Journal 11 (1992) 1025-1033.
17. Lees J. A., Fawell S. E. and Parker M. G., Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Research 17 (1989) 5477-5488.
18. Tasset D., Tora L., Fromental C., Scheer E. and Chambon P., Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62 (1990) 1177-1178.
19. Tzukerman M. T., Esty A., Santisomere D., Danielian P., Parker M. G., Stein R. B., Pike J. W. and McDonnell D. P., Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Molecular Endocrinology 8 (1994) 21-30.
20. Pierrat B., Heery D. M., Chambon P. and Losson R., A highly conserved region in the hormone-binding domain of the human estrogen receptor functions as an efficient transactivation domain in yeast. Gene 143 (1994) 193-200.
21. Fuqua S. A. W., Falette N. F. and McGuire W. L., Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay. Journal of National Cancer Institute 82 (1990) 858-861.
22. Fuqua S. A. W., Fitzgerald S. D., Chamness G. C., Tandon A. K., McDonnell D. P., Nawaz Z., O'Malley B. W. and McGuire W. L., Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Research 51 (1991) 105-109.
23. Rouet P., Raguenez G. and Salier J.-P., Optimized assays for quantifying transient expressions of co-transfected β-galactosidase and CAT-reporter genes. Biotechniques 13 (1992) 700-701.
24. Gorski K., Carneiro M. and Schibler U., Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47 (1986) 767-776.
25. Fuqua S. A. W., Allred D. C., Elledge R. M., Krieg S. L., Benedix M. G., Nawaz Z., O'Malley B. W., Greene G. L. and McGuire W. L., The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Breast Cancer Research Treatment 26 (1993) 191-202.
26. Castles C. G., Fuqua S. A. W., Klotz D. M. and Hill S. M., Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Research 53 (1993) 5934-5939.
27. Jacquemier J. D., Hassoun J., Torrente M. and Martin P. M., Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages - immunohistochemical study of 107 cases. Breast Cancer Research Treatment 15 (1990) 109-117.
28. Petrangeli E., Lubrano C., Ortolani F., Ravenna L., Vacca A., Sciacchitano S., Frati L. and Gulino A., Estrogen receptors: new perspectives in breast cancer management. Journal of Steroid Biochemistry & Molecular Biology 49 (1994) 327-331.
29. McGuire W. L. and De La Garza M. L., Improved sensitivity in the measurement of estrogen receptor in human breast cancer. Journal of Clinical Endocrinology and Metabolism 37 (1973) 986-989.
30. Henry J. A., Nicholson S., Hennessy C., Lennard T. W., May F. E. and Westley B. R., Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. British Journal of Cancer 61 (1990) 32-38.
31. Knight W. A. I., Livingston R. B., Gregory E. J. and McGuire W. L., Estrogen receptor is an independent prognostic factor for early recurrence in breast cancer. Cancer Research 37 (1977) 4669-4671.
32. Bishop H. M., Elston C. W., Blamey R. W., Haybittle J. L., Nicholson R. I. and Griffiths K., Relationship of oestrogen-receptor status to survival in breast cancer. Lancet 2 (1979) 283-284.
33. Weigel R. J. and deConinck E. C., Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Research 53 (1993) 3472-3474.
34. Ferguson A. T., Lapidus R. G., Baylin S. B. and Davidson N. E., Demethylation of the estrogen receptor gene in estrogen-receptor negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Research 55 (1995) 2279-2283.
35. Santoro C., Mermod N., Andrews P. C. and Tijan R., A family of human CCAAT-box-binding proteins active in transcription and DNA-replication: cloning and expression of multiple cDNAs. Nature 334 (1988) 218-224.
36. Ree A. H., Landmark B. F., Eskild W., Levy F. O., Lahooti H., Jahnsen T., Aakvaag A. and Hansson V., Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels. Endocrinology 124 (1989) 2577-2583.
37. Fuqua S. A. W., Fitzgerald S. D., Allred D. C., Elledge R. M., Nawaz Z., McDonnell D. P., O'Malley B. W., Greene G. L. McGuire W. L., Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Research 52 (1992) 483-486.
38. Ince B. A., Zhuang Y., Wrenn C. K., Shapiro D. J. and Katzenellenbogen B. S., Powerful dominant negative mutants of the human estrogen receptor. Journal of Biological Chemistry 268 (1993) 14026-14032.
39. Wang Y. and Miksicek R. J., Identification of a dominant negative form of the human estrogen receptor. Molecular Endocrinology 5 (1991) 1707-1715.
40. Baniahmad A., Leng X., Burris T. P., Tsai S. Y., Tsai M. J. O'Malley B. M., The tau2 activation domain of the thyroid hormone receptor is required to release a putative corepressor necessary for transcriptional silencing. Molecular & Cellular Biology 15 (1995) 76-86.
41. Gaub M. P., Bellard M., Scheuer I., Chambon P. and Sassone Corsi P., Activation of the ovalbumin gene by the estrogen recpetor involves the fos-jun complex. Cell 63 (1990) 1267-1276.
42. Elgort M. G., Zou A., Marschke K. B. and Allegretto E. A., Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-αl promoter via a novel sequence. Molecular Endocrinology 10 (1996) 477-487.